These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6289726

  • 1. In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
    Verbist L, Verhaegen J.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):222-5. PubMed ID: 6289726
    [Abstract] [Full Text] [Related]

  • 2. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.
    Neu HC, Meropol NJ, Fu KP.
    Antimicrob Agents Chemother; 1981 Mar; 19(3):414-23. PubMed ID: 6972729
    [Abstract] [Full Text] [Related]

  • 4. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH, Opfer BJ, Gerding DN.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
    Obaseiki-Ebor EE, Afonya TC, Oyaide SM.
    Chemotherapy; 1985 Feb; 31(2):130-7. PubMed ID: 3872779
    [Abstract] [Full Text] [Related]

  • 6. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A, Benonisen E, Dibb WL.
    Infection; 1982 Feb; 10(5):307-9. PubMed ID: 6293978
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
    Gu JW, Neu HC.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
    [Abstract] [Full Text] [Related]

  • 9. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A, Desnoes M, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
    Shannon K, King A, Warren C, Phillips I.
    Antimicrob Agents Chemother; 1980 Aug; 18(2):292-8. PubMed ID: 6969574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
    Jones RN, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ, Otterbein G, Le Van Thoi J, Duval J, Chanal M, Cluzel M, Sirot D.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.